Pasar al contenido principal

BIOLOGIA DE SISTEMAS BASADA EN PROTEOMICA Y BIOLOGIA ESTRUCTURAL EN LA ALERGIA AL PESCADO EN PRODUCTOS PESQUEROS FRESCOS Y PROCESADOS

PID2019-103845RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Rapid Shotgun Phosphoproteomics Analysis

  • Carrera, Mónica
  • Cañas, Benito
  • López-Ferrer, Daniel
10 pages, 4 figures, In this chapter, we describe a rapid workflow for the shotgun global phosphoproteomics analysis. The strategy is based on the use of accelerated in-solution trypsin digestion under an ultrasonic field by high-intensity focused ultrasound (HIFU) coupled to titanium dioxide (TiO2) selective phosphopeptide enrichment, fractionation by strong cation exchange chromatography (SCX), and analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a high-resolution mass spectrometer (LTQ-Orbitrap XL). The strategy was optimized for the global phosphoproteome analysis of Jurkat T-cells. Using this accelerated workflow, HIFU-TiO2-SCX-LC-MS/MS, 15,367 phosphorylation sites from 13,029 different phosphopeptides belonging to 3,163 different phosphoproteins can be efficiently identified in less than 15 h, This work was supported by the EU Marie Curie actions (FP7-PEOPLE-2012-IEF, ref. 332274), by the Ramon Areces Foundation (XVII National grant), by the GAIN-Xunta de Galicia Project (IN607D 2017/01) and by the Spanish AEI/EU-FEDER (PID2019-103845RB-C21) project, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Shotgun Proteomics and Protein-Based Bioinformatics for the Characterization of Food-Derived Bioactive Peptide

  • Carrera, Mónica
  • Pazos Don Pedro, Manuel
  • Aubourg, Santiago P.
  • Gallardo, José Manuel
9 pages, 1 figure, A workflow for the characterization of food-derived bioactive peptides is described in this chapter. The workflow integrates two consecutive steps: a discovery phase and a protein-based bioinformatic phase. In the first step (discovery phase), a shotgun bottom-up proteomics approach is used to create a reference data set for a selected food proteome. Afterward, in a second step (bioinformatic phase), the reference proteome is subjected to several in silico protein-based bioinformatic analyses to predict and characterize potential bioactive peptides after an in silico human gastrointestinal digestion. Using this workflow, bioactive collagen peptides, antihypertensive, antimicrobial, and antitumor peptides were predicted as potential valuable bioactive peptides from seafood and marine by-products. It is concluded that the combination of the global shotgun proteomic analysis and the analysis by protein-based bioinformatics can provide a rapid strategy for the characterization of new potential food-derived bioactive peptides, his work was supported by the GAIN-Xunta de Galicia Project (IN607D 2017/01) and the Spanish AEI/EU-FEDER (PID2019-103845RB-C21) project. Dr. Mónica Carrera is supported by the Ramón y Cajal contract (Ministry of Science and Innovation of Spain), No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

View expanded cover Vaccine Design pp 673–689Cite as Proteomics for Development of Food Allergy Vaccines

  • Carrera, Mónica
  • Magadán, Susana
17 pages, 1 table. 1 figure, Food allergy is a hypersensitivity reaction to food products initiated by immunologic mechanisms, which represents one of the major concerns in food safety. New therapies for food allergies including oral and epicutaneous allergen-specific immunotherapy are required, and B cell epitope-based allergy vaccines are a good promise to improve this field. In this chapter, we describe a workflow for the design of food allergy vaccines using proteomic tools. The strategy is defined based on the characterization of B cell epitopes for a particular food allergen. For that, the workflow comprises five consecutive steps: (1) shotgun proteomics analysis of different protein isoforms for a particular food allergen, (2) downloading all protein sequences for the specific allergen included in UniProtKB database, (3) analysis by protein-based bioinformatics of B cell epitopes, (4) synthesizing of the selected B cell peptide epitopes, and (5) performing of immunoassays using sera from healthy and allergic patients. The results from this method provide a rationale repository of B cell epitopes for the design of new specific immunotherapies for a particular food allergen. The strategy was optimized for all the beta-parvalbumins (β-PRVBs), which are considered as the main fish allergens. Using this workflow, a total of 35 peptides were identified as B cell epitopes, among them the top 4 B cell peptide epitopes that may induce protective immune response were selected as potential peptide vaccine candidates for fish allergy, This work was supported by the GAIN-Xunta de Galicia Project (IN607D 2017/01) and the Spanish AEI/EU-FEDER PID2019-103845RB-C21 project. Dr. Mónica Carrera is supported by the Ramón y Cajal contract (Ministry of Science and Innovation of Spain). Dr. Susana Magadan is supported by the Talent Retention program of Universidade de Vigo, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Finding novel immunotherapies for fish food allergy

  • Freire, Javier
  • Pazos Palmeiro, Manuel
  • Carrera, Mónica
  • Rojo, Francisco Javier
  • Magadán, Susana
Poster.-- VI Cinbio Annual Meeting, Nanomaterials and Biomedicine, 20-21 July 2023, Vigo, Fish is a prevalent cause of Type I hypersensitivity or immunoglobulin E (IgE)-mediated food allergy. Sensitized individuals are required to strictly avoid fish products throughout their lives, with a high risk of accidental exposure and a loss of quality of life. Allergen-specific immunotherapy (AIT) is a promising therapeutic approach that involves repeated doses of allergen extracts to create immunological tolerance. However, the effectiveness and safety profile of this strategy is not optimal and there is a need for more efficient AIT approaches. In this sense, the combination of immunodominant T cell epitope peptides and adjuvants appears to be a safer and powerful strategy to induce a Th1-polarized and regulatory immune response. However, different aspects need to be evaluated before approval for human application, including the capacity to decrease allergic adverse events, safety of the adjunctive therapies themselves, effect on long-term sustained unresponsiveness and cost. We developed an animal model for fish food allergy to conduct preclinical efficacy studies of new AITs for fish food allergy. We sensitized BALB/c mice using the allergen Mer mr 1 (the European hake parvalbumin, β-PRVB), leading to a Th2-like immune response (figure). A significant higher value of serum allergenspecific IgE, IgG1, and mouse mast cell protease-1 (mMCPT-1) were observed following allergen oral challenge. We performed different in vivo and ex vivo studies to evaluate the efficacy of new adjuvants and the immunogenicity of β-PRVB T-cell epitopes, which were predicted by in silico analysis. The results suggest this is a good animal model to test potential therapeutics for food allergy before clinical trials, This work supported by the Spanish Ministry of Science and Innovation (PID2019-103845RB-C21). Javier Freire is supported by Xunta de Galicia and GAIN with a predoctoral grant (ED481A-2021/356, No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Serum antibodies from parvalbumin-sensitized mice recognize linear epitopes from allergens

  • Freire, Javier
  • Pazos Palmeiro, Manuel
  • Carrera, Mónica
  • Magadán, Susana
1 page.-- Poster.-- VII Annual Meeting CINBIO, Science to think further, Vigo, 18th-19th of July, Type 1 hypersensitivity, also known as IgE-mediated allergy, is a growing concern in the world, especially for people living in urban areas in western countries. Food components are becoming increasingly relevant as allergen sources, being fish one of the 10 major sources of food allergens, with beta-parvalbumin being responsible for 80% of the allergic reactions. Fish allergic individuals must meticulously avoid fish products for life, facing substantial risk of accidental exposure and a high burden on quality of life and nutritional challenges. Current therapies are far from perfect as they lack long-term efficacy and adverse events are frequent, forcing the patients to abandon the therapy2,3. In this context, there is a need for more effective and safer therapies. In this context, the use of short peptides containing immunodominant T/B cell epitopes in conjunction with pharmacological adjuvants emerges as a promising therapy. Short peptides may lack the capacity to stimulate mast cells, which are responsible for the allergic symptoms, but they can retain the capacity to be recognized by T/B cells. Furthermore, when they are administered alone or with adjuvants they can activate a Th1-skewed and regulatory responses inducing long-lasting tolerance., In this work we tested peptides previously predicted to be T and/or B-cell epitopes to assess their capacity to bind antibodies from serum of mice sensitized with the whole protein. We performed a competitive ELISA assay that has a higher sensitivity than conventional, indirect ELISA assays, and measured their capacity to inhibit the binding of antibodies to the full protein. While we could determine the recognition of linear epitopes by antibodies, there are individual differences in the pattern of recognition, which is consistent with previous observations in humans4. These results can help identifying immunodominant peptides to be used in new immunotherapies for fish allergy, This work supported by the Spanish Ministry of Science and Innovation (PID2019-103845RB-C21). Javier Freire is supported by Xunta de Galicia and GAIN with a predoctoral grant (ED481A-2021/356), No